ImmunoGen, Inc.

AQR CAPITAL MANAGEMENT LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

77,523

Value ($000)

2,299

Weight

0.0%

2013 Q4 - 2023 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	2,299	0.0%	77,523	12/31/2023
2023 Q3	11/14/2023	1,994	0.0%	125,637	9/30/2023
2023 Q2	8/14/2023	489	0.0%	25,912	6/30/2023
2023 Q1	5/15/2023	95	0.0%	24,778	3/31/2023
2022 Q4	2/14/2023	130	0.0%	26,176	12/31/2022
2022 Q3	11/14/2022	125	0.0%	26,176	9/30/2022
2022 Q2	8/15/2022	137	0.0%	30,392	6/30/2022
2022 Q1	5/16/2022	1,144	0.0%	240,321	3/31/2022
2021 Q4	2/14/2022	1,429	0.0%	192,558	12/31/2021
2021 Q3	11/15/2021	1,083	0.0%	190,937	9/30/2021
2021 Q2	8/16/2021	1,439	0.0%	218,353	6/30/2021
2021 Q1	5/17/2021	1,096	0.0%	135,348	3/31/2021
2020 Q4	2/16/2021	583	0.0%	90,416	12/31/2020
2020 Q3	11/16/2020	852	0.0%	236,529	9/30/2020
2020 Q2	8/17/2020	1,598	0.0%	347,314	6/30/2020
2020 Q1	5/15/2020	948	0.0%	278,128	3/31/2020
2019 Q4	2/14/2020	1,206	0.0%	236,248	12/31/2019
2014 Q1	5/15/2014	345	0.0%	23,127	3/31/2014
2013 Q4	2/14/2014	339	0.0%	23,127	12/31/2013